Post entry

Active Biotech: "homage" i utländsk media för Laquinimod (MS) ...(!)

Please note: Community posts are written by its members and not by Redeye’s research department. As a reader you’re always encouraged to critically analyze the content.

LAQUINIMOD ROSAS ... " BRIGHT FUTURE FOR LAQUINIMOD ...(!) "

Från denna positiva artikel om Laquinimod, saxas sista stycket här nedan, som utgör en "homage" till den immunmodulerande, orala formuleringen Laquinimod:

" Indeed, the future seems bright for Laquinimod, especially with its new FDA fast track status. One can only hope that Laquinimod continues to dramatically reduce the rate of MS deterioration, without negative side effects.

What a blessing that would be for people suffering from relapsing-remitting multiple sclerosis! "

Källa:
Läs hela den positiva artikeln genom att klicka på nedanstående länk: http://jrn.biola.edu/~osterm_k/wordpress/?p=10

// EPOKEN

0 comments

You need to to read and post comments.

Does this article violate Redeye’s Rules & Guidelines?